Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sal-like protein 2 pseudogene (ENSG00000267187) is a DNA sequence in the human genome with significant similarity to the gene encoding Sal-like protein 2, a zinc finger transcription factor. Unlike its functional parent gene, pseudogenes of this type are characterized by disruptive mutations (e.g., frameshifts, premature stop codons), lack introns (if processed), and do not produce functional proteins. Pseudogenes may arise through gene duplication or retrotransposition followed by disabling mutations[2][1][4][5]. While some pseudogenes are transcribed and may participate in gene regulatory networks, there is no evidence that Sal-like 2 pseudogene has any biological function or disease association. These sequences are mainly relevant for genome annotation and may affect the accuracy of genetic variant analysis and diagnostics due to their sequence similarity with parent genes[7].
None applicable, as drugs do not target this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sal-like protein 2 pseudogene (No standard abbreviation; "SAL-like 2, pseudogene" is used, but common abbreviations are not established for pseudogenes.).